Abstract:The mechanism of bipolar disorder is unclear. Growing evidence indicates that gut microbiota plays a pivotal role in mental disorders. This study aimed to find out changes in the gut microbiota in bipolar depression (BD) subjects following treatment with quetiapine and evaluate their correlations with the brain and immune function. Totally 36 subjects with BD and 27 healthy controls (HCs) were recruited. The severity of depression was evaluated with the Montgomery-Asberg depression rating scale (MADRS). At baseline, fecal samples were collected and analyzed by quantitative polymerase chain reaction (qPCR). T lymphocyte subsets were measured to examine immune function. Near-infrared spectroscopy (NIRS) was used to assess brain function. All BD subjects received quetiapine treatment (300 mg/d) for four weeks, following which the fecal microbiota and immune profiles were reexamined. Here, we first put forward the new concept of brain-gut coefficient of balance (B-GCB), which referred to the ratio of [oxygenated hemoglobin]/(Bifidobacteria to Enterobacteriaceae ratio), to analyze the linkage between the gut microbiota and brain function. At baseline, the CD3+ T cell proportion was positively correlated with log10 Enterobacter spp count, whereas the correlativity between the other bacteria and immune profiles were negative. Log10 B-GCB was positively correlated with CD3+ T cell proportion. In subjects with BD, counts of Faecalibacterium prausnitzii, Bacteroides-Prevotella group, Atopobium Cluster, Enterobacter spp, and Clostridium Cluster IV were higher, whereas the log10 (B/E) were lower than HCs (B/E refers to Bifidobacteria to Enterobacteriaceae ratio and represents microbial colonization resistance). After treatment, MADRS scores were reduced, whereas the levels of Eubacterium rectale, Bifidobacteria, and B/E increased. The composition of the gut microbiota and its relationship to brain function were altered in BD subjects. Quetiapine treatment was effective for depression and influenced the composition of gut microbiota in patients. Clinical Trial Registration: http://www.chictr.org.cn/index.aspx, identifier ChiCTR-COC-17011401, URL: http://www.chictr.org.cn/listbycreater.aspx.

New Evidence of Gut Microbiota Involvement in the Neuropathogenesis of Bipolar Depression by TRANK1 Modulation: Joint Clinical and Animal Data

Impaired Blood‐brain Barrier in the Microbiota‐gut‐brain Axis: Potential Role of Bipolar Susceptibility Gene TRANK1

Impaired blood-brain barrier in the microbiota-gut-brain axis: Potential role of bipolar susceptibility gene <i>TRANK1</i>

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder

Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: an Advanced Exploration

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

Brain-gut Microbiota Multimodal Predictive Model in Patients with Bipolar Depression

Characteristics of the Gut Microbiota in Bipolar Depressive Disorder Patients with Distinct Weight.

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder

Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies

Metagenomic Analysis Reveals Gut Bacterial Signatures for Diagnosis and Treatment Outcome Prediction in Bipolar Depression.

Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in bipolar disorder with current major depressive episode patients

Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients

The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder

Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain

Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence

Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment

Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice

Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated with Depression by 16S Rrna Gene Sequencing and LC/MS-based Metabolomics.